Abiopharma

News list

Director Darnall Matthew S 🟢 acquired 10.5K shares (1 derivative) of OLIN Corp (OLN) Transaction Date: May 01, 2026 | Filing ID: 000002

Full text

News bot May 5, 2026, 5:52 p.m.
🔍 Darnall Matthew S (Director)

Company: OLIN Corp (OLN)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 10,535
Detailed Transactions and Holdings:
- Acquired 10,535 shares of Phantom Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 42,721.81 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Security converts to common stock on a one-to-one basis.
- F2: Represents a portion of the annual director compensation granted under the Olin Corporation Non-Employee Director Deferred Compensation Plan.